Bayesian Synthesis Finds LAAO Fails Stroke Non-Inferiority Versus Anticoagulation
For cardiology and anticoagulation pharmacists, this Bayesian pooled analysis quantifies the probability that percutaneous left atrial appendage occlusion matches oral anticoagulation for stroke prevention, and confirms its durable but partial bleeding advantage.
LAAO reduces bleeding but not strokes compared to anticoagulation.
Stroke prevention in atrial fibrillation requires balancing anticoagulation efficacy and bleeding risk. Left atrial appendage occlusion (LAAO) showed no significant advantage in stroke or systemic embolism (SSE) prevention over oral anticoagulation (OAC) but did reduce non-procedural clinically relevant bleeding (CRB). While LAAO may reduce bleeding, it does not clearly outperform OAC in preventing SSE, indicating heterogeneity and the need for patient-specific considerations. LAAO may reduce bleeding but lacks clear stroke prevention superiority over OAC.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Athmakuri KS, Nandyal SR, Pamreddy HR, Vinjamuri S, Lingamsetty SSP, Mahajan AV, Hussain M, Chaliki HP, Srivathsan K
Citation:Athmakuri KS, Nandyal SR, Pamreddy HR, et al. Comparative evaluation of left atrial appendage occlusion and oral anticoagulation: a Bayesian meta-analysis of randomized controlled trials. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2026;28(7). doi:10.1093/europace/euag163